Document 0291
 DOCN  M9460291
 TI    Multidrug-resistant tuberculosis: meeting the challenge.
 DT    9408
 AU    Reichman LB; University of Medicine and Dentistry of New Jersey-New
       Jersey; Medical School, Newark.
 SO    Hosp Pract (Off Ed). 1994 May 15;29(5):85-8, 91, 95-6. Unique Identifier
       : AIDSLINE MED/94230644
 AB    Both public and private institutions are mobilizing to combat
       drug-resistant TB--indeed, to eliminate all TB. Meeting this goal will
       require a three-pronged approach: 1) prophylactic isoniazid treatment of
       latent TB, 2) multidrug (at least six agents in some cases) treatment of
       active TB to eradicate resistant strains, and 3) correction of the
       social conditions that have contributed to the current epidemic.
 DE    Antitubercular Agents/ADMINISTRATION & DOSAGE  AIDS-Related
       Opportunistic Infections/DIAGNOSIS/DRUG THERAPY/  EPIDEMIOLOGY  Disease
       Outbreaks/STATISTICS & NUMER DATA  Drug Therapy, Combination  Human
       HIV-1  Patient Compliance  Prevalence  Tuberculosis,
       Multidrug-Resistant/DIAGNOSIS/*DRUG THERAPY/  EPIDEMIOLOGY
       Tuberculosis, Pulmonary/DIAGNOSIS/*DRUG THERAPY/EPIDEMIOLOGY  United
       States/EPIDEMIOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).